heparin trial summary

No demonstrated result

Endpoint	TE [95% CI]	p val	I2	n	k	trials
Deep vein thrombosis	no data
Venous thromboembolism end of treatment	no data
Venous thromboembolism	no data
Pain disappearance	no data
Major bleeding	no data
Extension and/or recurrence of SVT	no data
Heparin-induced thrombocytopenia	no data

TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients

No demonstrated result

Endpoint	TE [95% CI]	p val	I2	n	k	trials
Deep vein thrombosis	no data
Venous thromboembolism end of treatment	no data
Venous thromboembolism	no data
Pain disappearance	no data
Major bleeding	no data
Extension and/or recurrence of SVT	no data
Heparin-induced thrombocytopenia	no data

TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients

No demonstrated result

Endpoint	TE [95% CI]	p val	I2	n	k	trials
Deep vein thrombosis	no data
Venous thromboembolism end of treatment	no data
Venous thromboembolism	no data
Pain disappearance	no data
Major bleeding	no data
Extension and/or recurrence of SVT	no data
Heparin-induced thrombocytopenia	no data

TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients

No demonstrated result

Endpoint	TE [95% CI]	p val	I2	n	k	trials
Deep vein thrombosis	no data
Venous thromboembolism end of treatment	no data
Venous thromboembolism	no data
Pain disappearance	no data
Major bleeding	no data
Extension and/or recurrence of SVT	no data
Heparin-induced thrombocytopenia	no data

TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients

No demonstrated result

Endpoint	TE [95% CI]	p val	I2	n	k	trials
Deep vein thrombosis	no data
Venous thromboembolism end of treatment	no data
Venous thromboembolism	no data
Pain disappearance	no data
Major bleeding	no data
Extension and/or recurrence of SVT	no data
Heparin-induced thrombocytopenia	no data

TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients

No demonstrated result

Endpoint	TE [95% CI]	p val	I2	n	k	trials
recurrent DVT	no data
VTE	no data
fatal pulmonary embolism	no data
non-fatal pulmonary embolism	no data
Major bleeding	no data
any bleedings	no data
Fatal bleeding	no data
All cause death	no data

TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients

No demonstrated result

Endpoint	TE [95% CI]	p val	I2	n	k	trials
recurrent DVT	no data
VTE	no data
fatal pulmonary embolism	1.09 [0.06 19.85]	p=1.00	0	23	1	Ott importé,
non-fatal pulmonary embolism	no data
Major bleeding	no data
any bleedings	no data
Fatal bleeding	no data
All cause death	no data

TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients

No demonstrated result

Endpoint	TE [95% CI]	p val	I2	n	k	trials
Recurrent thromboembolic event	0.72 [0.38 1.36]	p=1.00	0	783	6	Bentley,Hull,Doyle,Walker,Lopaciuk,Pini,
Major bleeding	0.81 [0.40 1.64]	p=1.00	0	783	6	Bentley,Hull,Doyle,Walker,Lopaciuk,Pini,

TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients

Heparin antithrombotics